Health Care & Life Sciences » Biotechnology | Gene Techno Science Co. Ltd.

Gene Techno Science Co. Ltd. | Cash Flow

Fiscal year is April-March. All values JPY Thousands.
2014
2015
2016
2017
2018
2019
Net Income before Extraordinaries
516,780.00
373,657.00
785,785.00
1,222,134.00
902,657.00
854,391
Depreciation, Depletion & Amortization
433.00
323.00
246.00
347.00
313.00
716
Other Funds
-
9,469.00
-
-
-
4,184
Funds from Operations
490,932.00
360,228.00
782,332.00
1,156,217.00
905,319.00
857,859
Changes in Working Capital
238,672.00
55,323.00
174,957.00
603,026.00
466,947.00
2,457
Net Operating Cash Flow
729,604.00
304,905.00
607,375.00
1,759,243.00
438,372.00
860,316
Capital Expenditures
226.00
221.00
1,985.00
-
252.00
Purchase/Sale of Investments
-
49,995.00
119,761.00
149,902.00
-
Net Investing Cash Flow
1,666.00
458.00
121,746.00
149,902.00
50,252.00
Issuance/Reduction of Debt, Net
1,199,081.00
-
460,080.00
460,080.00
-
Net Financing Cash Flow
1,454,086.00
907,256.00
946,991.00
3,471,699.00
-
Net Change in Cash
722,816.00
601,893.00
217,870.00
1,562,554.00
488,624.00
Free Cash Flow
729,830.00
305,126.00
609,360.00
1,759,243.00
438,624.00
Net Assets from Acquisitions
-
-
-
-
50,000.00
Other Sources
1,900.00
-
-
-
-
Change in Capital Stock
255,005.00
916,725.00
486,911.00
3,931,779.00
-
Other Uses
3,340.00
237.00
-
-
-

About Gene Techno Science Co.

View Profile
Address
Wall Annex 502
Sapporo Hokkaido 060
Japan
Employees -
Website http://www.g-gts.com
Updated 07/08/2019
Gene Techno Science Co., Ltd. engages in the research and development of biopharmaceutical products. Its products include antibodies, oligosaccharides, small interfering ribonucleic acids, proteins, and peptides. The company was founded on March 1, 2001 and is headquartered in Sapporo, Japan.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.